Salvinorin A (Divinorin A), kappa agonist (CAS 83729-01-5) (ab120084) | Abcam
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Effects of the Kappa Agonist U69,593 on Naltrexone's Discriminative Stimulus Effect in Subjects Given Chronic, Intermittent Sucrose Access
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia
Mu Agonist Opioids and Kappa Opioids | Download Table
Nephrology Journal Club on X: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
Can Kappa and Alpha-2 Agonist Agents Treat Opioid-Induced Ventilatory Depression Risk While Preserving Analgesic Effects? – Consult QD
Opioids in cancer: The κ‑opioid receptor (Review)
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
κ-Opioid Receptor (KOP) | 7TM Antibodies
Kappa Receptors – Opioid Peptides
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Discovery and Binding Mechanism of Pyrazoloisoquinoline-Based Novel β-Arrestin Inverse Agonists of the Kappa-Opioid Receptor | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
